{"transactions":[{"id":1859664,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-12T08:57:59.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":721154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable upon the eleventh month anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable upon the eleventh month anniversary of the date of grant."}],"balance_after":779901,"derivative":{"underlying":"Common Stock","underlying_shares":721154},"source":{"system":"sec-edgar","filing":"0001209191-23-036142","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919123036142/doc4.xml","form_type":"4"}},{"id":2092718,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-08T21:48:57.000Z","date":"2022-12-07","kind":"sale","acquired":false,"shares":3537,"price":0.75,"value":2652.75,"ownership":{"direct":true},"balance_after":59925,"source":{"system":"sec-edgar","filing":"0001209191-22-060435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919122060435/doc4.xml","form_type":"4"}},{"id":2274154,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-12T21:59:49.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":58747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable upon the  one year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable upon the  one year anniversary of the date of grant."}],"balance_after":58747,"derivative":{"underlying":"Common Stock","underlying_shares":58747},"source":{"system":"sec-edgar","filing":"0001209191-22-028740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919122028740/doc4.xml","form_type":"4"}},{"id":2287142,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series G Preferred Stock","published_at":"2022-05-02T13:48:29.000Z","date":"2022-04-28","kind":"disposition_to_issuer","acquired":false,"shares":1395.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 1, 2022, the Company's board of directors (the \"Board\") declared a dividend of one one-thousandth of a share of Series G Preferred Stock, par value $0.001 per share (\"Preferred Stock\"), for each outstanding share of Company Common Stock to stockholders of record at 5:00 p.m. Eastern Time on March 25, 2022 (the \"Record Date\"), in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on March 25, 2022. As a result, the Reporting Person received 1,395.41 shares of Preferred Stock. The Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"On April 28, 2022, these shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation for the shares of Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.01 in cash for each ten whole shares of Preferred Stock, with any remaining shares (of less than 10) receiving no cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 28, 2022, these shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation for the shares of Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.01 in cash for each ten whole shares of Preferred Stock, with any remaining shares (of less than 10) receiving no cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-016099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000089924322016099/doc4.xml","form_type":"4"}},{"id":2470769,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T18:38:52.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":11038,"price":0.38,"value":4194.44,"ownership":{"direct":true},"balance_after":633096,"source":{"system":"sec-edgar","filing":"0001209191-21-070069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919121070069/doc4.xml","form_type":"4"}},{"id":2670990,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-14T20:50:13.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock unit award fully vests and is immediately exercisable upon the  filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock unit award fully vests and is immediately exercisable upon the  filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023."}],"balance_after":330000,"derivative":{"underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001209191-21-040456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919121040456/doc4.xml","form_type":"4"}},{"id":2670989,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Right","published_at":"2021-06-14T20:50:13.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":189902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Of the stock appreciation rights subject to this SAR, one-fourth of the stock appreciation rights vest on each of the third, sixth, ninth, and twelfth-month anniversaries of the date of grant."}],"balance_after":189902,"derivative":{"exercise_price":0.84,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":189902},"source":{"system":"sec-edgar","filing":"0001209191-21-040456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919121040456/doc4.xml","form_type":"4"}},{"id":3064077,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-08-10T09:51:05.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award, subject to the Reporting Person's continued service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award, subject to the Reporting Person's continued service."}],"balance_after":443602,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-045876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919120045876/doc4.xml","form_type":"4"}},{"id":3077205,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Convertible Preferred","published_at":"2020-07-23T18:40:19.000Z","date":"2020-07-22","kind":"grant","acquired":true,"shares":6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"An investment of $1,000 in the Issuer's rights offering provided the Reporting Person with one share of Series E Preferred Stock and 2,500 Warrants, which are the subject securities reported by the Reporting Person in this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series F Preferred Stock will be convertible at the Issuer's option at any time on or after July 15, 2021 or at the option of the Reporting Person at any time, into the number of shares of the Issuer's common stock determined by dividing the $1,000 stated value per share of the Series E Preferred Stock by a Conversion Price of $0.40 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Series F Preferred Stock will be convertible at the Issuer's option at any time on or after July 15, 2021 or at the option of the Reporting Person at any time, into the number of shares of the Issuer's common stock determined by dividing the $1,000 stated value per share of the Series E Preferred Stock by a Conversion Price of $0.40 per share."}],"balance_after":6,"derivative":{"exercise_price":0.4,"exercise_date":"2020-07-22","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001209191-20-043538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919120043538/doc4.xml","form_type":"4"}},{"id":3077204,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2020-07-23T18:40:19.000Z","date":"2020-07-22","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"An investment of $1,000 in the Issuer's rights offering provided the Reporting Person with one share of Series E Preferred Stock and 2,500 Warrants, which are the subject securities reported by the Reporting Person in this Form 4."}],"balance_after":15000,"derivative":{"exercise_price":0.4,"exercise_date":"2020-07-22","expiration_date":"2025-07-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-043538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919120043538/doc4.xml","form_type":"4"}},{"id":3132858,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-28T11:46:31.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":330178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and is immediately exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service."}],"balance_after":443659,"derivative":{"exercise_price":0.3752,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":330178},"source":{"system":"sec-edgar","filing":"0001209191-20-032521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919120032521/doc4.xml","form_type":"4"}},{"id":3132857,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-05-28T11:46:31.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":291178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award, subject to the Reporting Person's continued service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award, subject to the Reporting Person's continued service."}],"balance_after":423602,"derivative":{"underlying":"Common Stock","underlying_shares":291178},"source":{"system":"sec-edgar","filing":"0001209191-20-032521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919120032521/doc4.xml","form_type":"4"}},{"id":3442900,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-08-09T10:54:47.000Z","date":"2019-08-07","kind":"grant","acquired":true,"shares":132424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable on the nine month anniversary of the date of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award fully vests and is immediately exercisable on the nine month anniversary of the date of the award."}],"balance_after":709569,"derivative":{"underlying":"Common Stock","underlying_shares":132424},"source":{"system":"sec-edgar","filing":"0001209191-19-045263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919119045263/doc4.xml","form_type":"4"}},{"id":3757958,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-20T19:54:12.000Z","date":"2018-11-16","kind":"purchase","acquired":true,"shares":10000,"price":1.36,"value":13600.0,"ownership":{"direct":true},"balance_after":577145,"source":{"system":"sec-edgar","filing":"0001209191-18-059595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919118059595/doc4.xml","form_type":"4"}},{"id":3845375,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-14T18:29:11.000Z","date":"2018-08-14","kind":"purchase","acquired":true,"shares":30598,"price":1.45,"value":44367.1,"ownership":{"direct":true},"balance_after":567145,"source":{"system":"sec-edgar","filing":"0001209191-18-046678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919118046678/doc4.xml","form_type":"4"}},{"id":3845374,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-14T18:29:11.000Z","date":"2018-08-10","kind":"purchase","acquired":true,"shares":69402,"price":1.25,"value":86752.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.17 to $1.35, inclusive. The reporting person undertakes to provide to Biolase, Inc., any security holder of Biolase, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":536547,"source":{"system":"sec-edgar","filing":"0001209191-18-046678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919118046678/doc4.xml","form_type":"4"}},{"id":3936149,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-05-14T17:49:25.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":144828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award."}],"balance_after":172140,"derivative":{"underlying":"Common Stock","underlying_shares":144828},"source":{"system":"sec-edgar","filing":"0001209191-18-029962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919118029962/doc4.xml","form_type":"4"}},{"id":3936148,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-05-14T17:49:25.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":27312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as follows: (i) two-fifths of the restricted stock units vest on December 31, 2018, and (ii) three-fifths of the restricted\nstock units vest on December 31, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as follows: (i) two-fifths of the restricted stock units vest on December 31, 2018, and (ii) three-fifths of the restricted\nstock units vest on December 31, 2019."}],"balance_after":27312,"derivative":{"underlying":"Common Stock","underlying_shares":27312},"source":{"system":"sec-edgar","filing":"0001209191-18-029962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919118029962/doc4.xml","form_type":"4"}},{"id":3936147,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-05-14T17:49:25.000Z","date":"2018-05-11","kind":"exercise","acquired":false,"shares":7042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 10, 2017, the reporting person was granted 35,211 restricted stock units, which vested on May 11, 2018. On May 10, 2018, the Company issued a press release announcing that, at the Annual Meeting, the Company's stockholders approved a proposal to amend the Company's Restated Certificate of Incorporation to effect a reverse stock split of Company common stock at a ratio of not less than 1-for-5 and not more than 1-for-15, with the final ratio to be determined by the Board. Immediately after the Annual Meeting, the Board approved the reverse stock split at a ratio of one post-split share for every five pre-split shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 10, 2017, the reporting person was granted 35,211 restricted stock units, which vested on May 11, 2018. On May 10, 2018, the Company issued a press release announcing that, at the Annual Meeting, the Company's stockholders approved a proposal to amend the Company's Restated Certificate of Incorporation to effect a reverse stock split of Company common stock at a ratio of not less than 1-for-5 and not more than 1-for-15, with the final ratio to be determined by the Board. Immediately after the Annual Meeting, the Board approved the reverse stock split at a ratio of one post-split share for every five pre-split shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7042},"source":{"system":"sec-edgar","filing":"0001209191-18-029962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919118029962/doc4.xml","form_type":"4"}},{"id":3936146,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T17:49:25.000Z","date":"2018-05-11","kind":"exercise","acquired":true,"shares":7042,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":100470,"source":{"system":"sec-edgar","filing":"0001209191-18-029962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919118029962/doc4.xml","form_type":"4"}},{"id":4140973,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subscription Rights (Right to Buy)","published_at":"2017-12-06T11:20:32.000Z","date":"2017-12-05","kind":"other","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.456,"exercise_date":"2017-11-08","expiration_date":"2017-11-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-17-064132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117064132/doc4.xml","form_type":"4"}},{"id":4140972,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-06T11:20:32.000Z","date":"2017-12-05","kind":"other","acquired":true,"shares":100000,"price":0.456,"value":45600.0,"ownership":{"direct":true},"balance_after":467145,"source":{"system":"sec-edgar","filing":"0001209191-17-064132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117064132/doc4.xml","form_type":"4"}},{"id":4168281,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-09T19:22:05.000Z","date":"2017-11-08","kind":"grant","acquired":true,"shares":19737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and is exercisable in equal monthly installments over a consecutive 6-month period, commencing December 10, 2017."}],"balance_after":578131,"derivative":{"exercise_price":0.57,"expiration_date":"2027-11-08","underlying":"Common Stock","underlying_shares":19737},"source":{"system":"sec-edgar","filing":"0001209191-17-060088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117060088/doc4.xml","form_type":"4"}},{"id":4211003,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-13T16:37:09.000Z","date":"2017-09-12","kind":"grant","acquired":true,"shares":65891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and is exercisable in equal monthly installments over a consecutive 8-month period, commencing October 10, 2017."}],"balance_after":558394,"derivative":{"exercise_price":0.61,"expiration_date":"2027-09-12","underlying":"Common Stock","underlying_shares":65891},"source":{"system":"sec-edgar","filing":"0001209191-17-052621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117052621/doc4.xml","form_type":"4"}},{"id":4211002,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-13T16:37:09.000Z","date":"2017-09-11","kind":"grant","acquired":true,"shares":65385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and is exercisable in equal monthly installments over a consecutive 8-month period, commencing October 10, 2017."}],"balance_after":492503,"derivative":{"exercise_price":0.54,"expiration_date":"2027-09-11","underlying":"Common Stock","underlying_shares":65385},"source":{"system":"sec-edgar","filing":"0001209191-17-052621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117052621/doc4.xml","form_type":"4"}},{"id":4268195,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Participating Convertible Preferred Stock","published_at":"2017-07-03T17:44:37.000Z","date":"2017-06-30","kind":"exercise","acquired":false,"shares":768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These shares of Series D Participating Convertible Preferred Stock (\"Preferred Stock\") were acquired by Jonathan T. Lord in a private placement with the Issuer, which closed on April 18, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":1.24,"exercise_date":"2017-06-30","underlying":"Common Stock","underlying_shares":76800},"source":{"system":"sec-edgar","filing":"0001209191-17-042883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117042883/doc4.xml","form_type":"4"}},{"id":4268194,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-03T17:44:37.000Z","date":"2017-06-30","kind":"exercise","acquired":true,"shares":76800,"price":1.24,"value":95232.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 30, 2017, as a result of receipt of the Requisite Stockholder Approval (defined and described further in the Securities Purchase\nAgreement dated April 11, 2017 and filed as Exhibit 99.1 to the Current Report on Form 8-K filed by the Issuer on April 14, 2017), each share of\nPreferred Stock (as defined below) automatically converted into 100 shares of Common Stock, reflecting a conversion price equal to $1.24 per\nshare."}],"balance_after":430490,"source":{"system":"sec-edgar","filing":"0001209191-17-042883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117042883/doc4.xml","form_type":"4"}},{"id":4323926,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-05-12T16:08:25.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":35211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award."}],"balance_after":35211,"derivative":{"underlying":"Common Stock","underlying_shares":35211},"source":{"system":"sec-edgar","filing":"0001209191-17-031889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117031889/doc4.xml","form_type":"4"}},{"id":4323925,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-12T16:08:25.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":105634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and is exercisable in equal monthly installments over a consecutive 12-month period, commencing one month from the date of grant."}],"balance_after":427118,"derivative":{"exercise_price":1.21,"expiration_date":"2027-05-10","underlying":"Common Stock","underlying_shares":105634},"source":{"system":"sec-edgar","filing":"0001209191-17-031889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117031889/doc4.xml","form_type":"4"}},{"id":4327341,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-05-10T16:14:11.000Z","date":"2017-05-08","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2016, the reporting person was granted 50,000 restricted stock units, which vested on May 6, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2016, the reporting person was granted 50,000 restricted stock units, which vested on May 6, 2017."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-031233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117031233/doc4.xml","form_type":"4"}},{"id":4327340,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-10T16:14:11.000Z","date":"2017-05-08","kind":"exercise","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":353690,"source":{"system":"sec-edgar","filing":"0001209191-17-031233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117031233/doc4.xml","form_type":"4"}},{"id":4350243,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2017-04-19T19:40:00.000Z","date":"2017-04-18","kind":"purchase","acquired":true,"shares":37387,"price":0.125,"value":4673.375,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of Series D Participating Convertible Preferred Stock (\"Preferred Stock\") and Warrants were acquired by Jonathan T. Lord in a private placement with the Issuer that closed on April 18, 2017 (the \"Closing\")."}],"balance_after":37387,"derivative":{"exercise_price":1.8,"exercise_date":"2017-10-18","expiration_date":"2022-04-18","underlying":"Common Stock","underlying_shares":37387},"source":{"system":"sec-edgar","filing":"0001209191-17-027589","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117027589/doc4.xml","form_type":"4"}},{"id":4350242,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Participating Convertible Preferred Stock","published_at":"2017-04-19T19:40:00.000Z","date":"2017-04-18","kind":"purchase","acquired":true,"shares":768,"price":124,"value":95232.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of Series D Participating Convertible Preferred Stock (\"Preferred Stock\") and Warrants were acquired by Jonathan T. Lord in a private placement with the Issuer that closed on April 18, 2017 (the \"Closing\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Preferred Stock will initially be convertible into 100 shares of Common Stock (\"Shares\"), reflecting a conversion price equal to $1.24 per Share. The conversion of the Preferred Stock will occur automatically upon the Requisite Stockholder Approval (defined and described further in the Securities Purchase Agreement dated April 11, 2017 and filed as Exhibit 99.1 to the Current Report on Form 8-K filed by the Issuer on April 14, 2017), which is expected to occur after the Closing. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Preferred Stock will initially be convertible into 100 shares of Common Stock (\"Shares\"), reflecting a conversion price equal to $1.24 per Share. The conversion of the Preferred Stock will occur automatically upon the Requisite Stockholder Approval (defined and described further in the Securities Purchase Agreement dated April 11, 2017 and filed as Exhibit 99.1 to the Current Report on Form 8-K filed by the Issuer on April 14, 2017), which is expected to occur after the Closing. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Preferred Stock will initially be convertible into 100 shares of Common Stock (\"Shares\"), reflecting a conversion price equal to $1.24 per Share. The conversion of the Preferred Stock will occur automatically upon the Requisite Stockholder Approval (defined and described further in the Securities Purchase Agreement dated April 11, 2017 and filed as Exhibit 99.1 to the Current Report on Form 8-K filed by the Issuer on April 14, 2017), which is expected to occur after the Closing. The Preferred Stock has no expiration date."}],"balance_after":768,"derivative":{"underlying":"Common Stock","underlying_shares":76800},"source":{"system":"sec-edgar","filing":"0001209191-17-027589","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117027589/doc4.xml","form_type":"4"}},{"id":4588746,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Participating Convertible Preferred Stock","published_at":"2016-10-04T17:26:57.000Z","date":"2016-09-30","kind":"exercise","acquired":false,"shares":1770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These shares of Series C Participating Convertible Preferred Stock (\"Preferred Stock\") were acquired by Jonathan T. Lord in a private placement with the Issuer, which closed on August 8, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":1.13,"exercise_date":"2016-09-30","underlying":"Common Stock","underlying_shares":177000},"source":{"system":"sec-edgar","filing":"0001209191-16-144507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919116144507/doc4.xml","form_type":"4"}},{"id":4588745,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-04T17:26:57.000Z","date":"2016-09-30","kind":"exercise","acquired":true,"shares":177000,"price":1.13,"value":200010.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 30, 2016, as a result of receipt of the Requisite Stockholder Approval (defined and described further in the Securities Purchase Agreement dated August 1, 2016 and filed as Exhibit 99.1 to the Current Report on Form 8-K filed by the Issuer on August 2, 2016), each share of Preferred Stock (as defined below) automatically converted into 100 shares of Common Stock, reflecting a conversion price equal to $1.13 per share."}],"balance_after":303690,"source":{"system":"sec-edgar","filing":"0001209191-16-144507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919116144507/doc4.xml","form_type":"4"}},{"id":4611810,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":112478,"kind":"person","name":"LORD JONATHAN T MD","position":1,"cik":"0001112980","reported_name":"LORD JONATHAN T MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-06T19:34:30.000Z","date":"2016-09-01","kind":"sale","acquired":false,"shares":10000,"price":91.5,"value":915000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Since the date of the reporting person's last Form 4, 63,553 shares of Dexcom Inc. Common stock were transferred to his former spouse pursuant to a domestic relations order.  Included in this number are 4,791 unvested restricted stock units which were granted on May 25, 2016 and shall vest on May 25, 2017."}],"balance_after":52820,"source":{"system":"sec-edgar","filing":"0001093557-16-000672","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1112980/000109355716000672/edgardoc.xml","form_type":"4"}}]}